| 1 |
Shen WY, Jia CP, Liao LY, Chen LL, Yuan CC, Gu YQ, Liu YH, Liang H, Chen ZF. Copper(II) complex enhanced chemodynamic therapy through GSH depletion and autophagy flow blockade. Dalton Trans 2023;52:3287-94. [PMID: 36691961 DOI: 10.1039/d2dt04108a] [Reference Citation Analysis]
|
| 2 |
Vera DR, Ardila DM, Palma A, Cobo J, Glidewell C. Conversion of 2-methyl-4-styrylquinolines into 2,4-distyrylquinolines: synthesis, and spectroscopic and structural characterization of five examples. Acta Crystallogr C Struct Chem 2023;79:94-103. [PMID: 36871291 DOI: 10.1107/S2053229623001432] [Reference Citation Analysis]
|
| 3 |
Christidou A, Zavalani K, Hatzidimitriou AG, Psomas G. Copper(II) complexes with 3,5-dihalogeno-salicylaldehydes: Synthesis, structure and interaction with DNA and albumins. J Inorg Biochem 2023;238:112049. [PMID: 36327500 DOI: 10.1016/j.jinorgbio.2022.112049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Prathapan P. Magic bullets, magic shields, and antimicrobials in between. Pharmaceutical Science Advances 2022. [DOI: 10.1016/j.pscia.2022.100002] [Reference Citation Analysis]
|
| 5 |
El-sheref EM, Tawfeek HN, Hassan AA, Bräse S, Elbastawesy MAI, Gomaa HAM, Mostafa YA, Youssif BGM. Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties. Front Chem 2022;10. [DOI: 10.3389/fchem.2022.1039176] [Reference Citation Analysis]
|
| 6 |
Feng Q, Yang W, Peng Z, Wang G. Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy. European Journal of Pharmacology 2022;934:175319. [DOI: 10.1016/j.ejphar.2022.175319] [Reference Citation Analysis]
|
| 7 |
Domińska M, Pastuch-Gawołek G, Skonieczna M, Szeja W, Domiński A, Kurcok P. Glycoconjugation of Quinoline Derivatives Using the C-6 Position in Sugars as a Strategy for Improving the Selectivity and Cytotoxicity of Functionalized Compounds. Molecules 2022;27:6918. [PMID: 36296513 DOI: 10.3390/molecules27206918] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Diaconu D, Antoci V, Mangalagiu V, Amariucai-Mantu D, Mangalagiu II. Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity. Sci Rep 2022;12:16988. [PMID: 36216981 DOI: 10.1038/s41598-022-21435-6] [Reference Citation Analysis]
|
| 9 |
Kadela-tomanek M, Jastrzębska M, Chrobak E, Bębenek E, Latocha M. Hybrids of 1,4-Quinone with Quinoline Derivatives: Synthesis, Biological Activity, and Molecular Docking with DT-Diaphorase (NQO1). Molecules 2022;27:6206. [DOI: 10.3390/molecules27196206] [Reference Citation Analysis]
|
| 10 |
Guo Y, Gao Q. Recent advances in 3-aminoindazoles as versatile synthons for the synthesis of nitrogen heterocycles. Org Biomol Chem 2022. [PMID: 36043318 DOI: 10.1039/d2ob01348g] [Reference Citation Analysis]
|
| 11 |
Cesaretti A, Mencaroni L, Bonaccorso C, Botti V, Calzoni E, Carlotti B, Fortuna CG, Montegiove N, Spalletti A, Elisei F. Amphiphilicity-Controlled Localization of Red Emitting Bicationic Fluorophores in Tumor Cells Acting as Bio-Probes and Anticancer Drugs. Molecules 2022;27:3713. [PMID: 35744843 DOI: 10.3390/molecules27123713] [Reference Citation Analysis]
|
| 12 |
Wu X, Zhang Y, Liu S, Liu C, Tang G, Cao X, Lei X, Peng J. Research applications of “linkers” in small molecule drugs design in fragment-based. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105921] [Reference Citation Analysis]
|
| 13 |
Zaraei SO, Al-Ach NN, Anbar HS, El-Gamal R, Tarazi H, Tokatly RT, Kalla RR, Munther MA, Wahba MM, Alshihabi AM, Shehata MK, Sbenati RM, Shahin AI, El-Awady R, Al-Tel TH, El-Gamal MI. Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity. Eur J Med Chem 2022;238:114434. [PMID: 35551038 DOI: 10.1016/j.ejmech.2022.114434] [Reference Citation Analysis]
|
| 14 |
Bai Y, Yang C, Deng N, Zhang M, Zhang Z, Li L, Zhou Y, Luo X, Xu C, Zhang B, Ma Y, Liu Y. Design and Synthesis of Novel 7-Ethyl-10-Fluoro-20-O-(Cinnamic Acid Ester)-Camptothecin Derivatives as Potential High Selectivity and Low Toxicity Topoisomerase I inhibitors for Hepatocellular Carcinoma. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115049] [Reference Citation Analysis]
|
| 15 |
Joksimović N, Petronijević J, Radisavljević S, Petrović B, Mihajlović K, Janković N, Milović E, Milivojević D, Ilić B, Djurić A. Synthesis, characterization, antitumor potential, and investigation of mechanism of action of copper(ii) complexes with acylpyruvates as ligands: interactions with biomolecules and kinetic study. RSC Adv 2022;12:30501-30513. [DOI: 10.1039/d2ra05797b] [Reference Citation Analysis]
|
| 16 |
Kakoulidou C, Chasapis CT, Hatzidimitriou AG, Fylaktakidou KC, Psomas G. Transition metal(ii) complexes of halogenated derivatives of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: structure, antioxidant activity, DNA-binding DNA photocleavage, interaction with albumin and in silico studies. Dalton Trans 2022. [DOI: 10.1039/d2dt02622h] [Reference Citation Analysis]
|
| 17 |
Hammoud MM, Nageeb AS, Morsi MA, Gomaa EA, Elmaaty AA, Al-karmalawy AA. Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers. New J Chem 2022;46:11422-36. [DOI: 10.1039/d2nj01646j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Zaib S, Munir R, Younas MT, Kausar N, Ibrar A, Aqsa S, Shahid N, Asif TT, Alsaab HO, Khan I. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. Molecules 2021;26:6573. [PMID: 34770983 DOI: 10.3390/molecules26216573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
